SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJudges Scientific Regulatory News (JDG)

Share Price Information for Judges Scientific (JDG)

Share Price is delayed by 15 minutes
Get Live Data
4,560.00    110.00 (2.47%)
Bid:
4,530.00
Ask:
4,590.00
Spread: 60.00 (1.325%)
Market Cap: £303.73m
JDG Live PriceLast checked at - London Stock Exchange

Intraday Judges Scientific Share Chart

Trading Statement

18 Jul 2012 07:00

RNS Number : 8953H
Judges Scientific PLC
18 July 2012
 

 

 

Judges Scientific plc

Trading Statement

18 July 2012

Judges Scientific plc ('Judges Scientific', the 'Company' or the 'Group')

Trading Update

The Directors of Judges Scientific, the parent company of a group engaged in the design, manufacture and sale of scientific instruments, are pleased to update shareholders and the market with regard to the Group's trading performance during the first half of the current financial year.

The Group recorded a solid trading performance during the period to 30 June 2012. The interim results, scheduled to be announced in September, are expected to show organic revenue growth of almost 8% compared with the six months to 30 June 2011. This advance in revenue increases to 39% when account is taken of businesses purchased since 1 January 2011, including a full six months of turnover from Deben and a first time contribution from Global Digital Systems ("GDS") and KE Developments ("KED"). The Board anticipates that interim profits and earnings per share before exceptional items will reflect this satisfactory performance.

GDS and KED were acquired on 6 March 2012 and both have since traded in line with management's expectations. The KED business was successfully relocated into Deben's Woolpit premises during the course of June 2012.

Order intake during the six-month period showed organic growth of 14%. The order book at 30 June 2012 represented ten weeks of sales, somewhat ahead of the level at the beginning of the year, partly as a result of the strong order intake and partly due to the fact that GDS's order book tends to be longer than the Group average.

The balance sheet will show a comfortable cash surplus as at 30 June 2012. Net debt had been eliminated altogether by the end of February, before £8.0 million was borrowed in March to finance the acquisition of GDS. However, the share placing in May raised £2.8 million (net) and this can be assumed to have reduced the level of gearing to less than one-times pro-forma historic EBITA.

The Board continues to be mindful that the global economic climate is fraught with uncertainty. Public spending restraint in Europe, the strength of Sterling, the embattled status of the Euro and fears of deceleration in China are all factors which are capable of affecting our businesses. There can be no complacency and the Board views the current trading environment with balanced measures of vigilance and confidence.

Enquiries:

David Cicurel, CEO, Judges Scientific: Tel: 01342 323 600

Pascal Keane, Edwards Mansfield, Shore Capital: Tel: 020 7408 4090

Melvyn Marckus, Cardew Group: Tel: 07775 896 491

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTZMGMNRNRGZZM
Date   Source Headline
6th Nov 201811:51 amRNSDirector/PDMR Shareholding
30th Oct 201810:00 amRNSTotal Voting Rights
9th Oct 20182:09 pmRNSDirector/PDMR Shareholding
18th Sep 20187:00 amRNSInterim Results
6th Sep 20184:22 pmRNSDirector/PDMR Shareholding
8th Aug 20183:25 pmRNSDirector/PDMR Shareholding
8th Aug 20187:00 amRNSIncrease in shareholding in PE Fiberoptics Limited
31st Jul 20188:21 amRNSTotal Voting Rights
27th Jul 20186:00 pmRNSDirector/PDMR Shareholding (Replacement)
27th Jul 201811:14 amRNSDirector/PDMR Shareholding
23rd Jul 20187:00 amRNSTrading Update and Notice of Interim Results
16th Jul 20187:00 amRNSHolding(s) in Company
9th Jul 20181:55 pmRNSDirector/PDMR Shareholding
15th Jun 20183:56 pmRNSHolding(s) in Company
7th Jun 20189:32 amRNSDirector/PDMR Shareholding
4th Jun 201810:48 amRNSTotal Voting Rights
30th May 20186:07 pmRNSResult of AGM
23rd May 20187:00 amRNSDirectorate Change
15th May 20187:00 amRNSBlock listing Interim Review
11th May 20187:00 amRNSDirector/PDMR Shareholding
1st May 20187:00 amRNSTotal Voting Rights
27th Apr 20189:26 amRNSNew Bank Facilities
10th Apr 20187:00 amRNSDirector/PDMR Shareholding
6th Apr 20187:00 amRNSExercise of Options and Director Dealing
20th Mar 20187:00 amRNSPreliminary Results
8th Mar 20187:00 amRNSDirector/PDMR Shareholding
1st Mar 20183:33 pmRNSTotal Voting Rights
7th Feb 201812:48 pmRNSDirector/PDMR Shareholding
1st Feb 20187:00 amRNSTotal Voting Rights
24th Jan 20185:02 pmRNSIssue of Equity - Blocklisting
15th Jan 20187:00 amRNSTrading Statement and Notice of Final Results
9th Jan 20189:32 amRNSDirector/PDMR Shareholding
9th Jan 20189:32 amRNSDirector/PDMR Shareholding
2nd Jan 201810:12 amRNSTotal Voting Rights
13th Dec 201712:27 pmRNSHolding(s) in Company
7th Dec 201710:58 amRNSDirector/PDMR Shareholding
1st Dec 20177:00 amRNSTotal Voting Rights
17th Nov 20174:43 pmRNSStandard form for notification of major holdings
16th Nov 201711:24 amRNSBlock listing Interim Review
13th Nov 20175:22 pmRNSNotification of major holdings
8th Nov 201710:15 amRNSDirector/PDMR Shareholding
1st Nov 20177:00 amRNSTotal Voting Rights
31st Oct 20177:00 amRNSAppointment of Director and Board transition
26th Oct 20172:25 pmRNSDirector/PDMR Shareholding
26th Oct 201712:19 pmRNSDirector/PDMR Shareholding
16th Oct 201712:03 pmRNSNotification of major holdings
10th Oct 20177:00 amRNSCompletion of Director Placing
9th Oct 20174:40 pmRNSPropose Director Placing
6th Oct 201711:23 amRNSDirector/PDMR Shareholding
2nd Oct 20177:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.